Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios Fountas

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Endocrinology and Metabolism Clinics of North America|August 4, 2020
Nelson's Syndrome: An UpdateAthanasios Fountas, Niki Karavitaki
European Journal of Endocrinology|October 18, 2024
Response to commentary "Vasopressin deficiency following operated craniopharyngiomas: fear or fatality?"Athanasios Fountas, Niki Karavitaki
Medicina (Kaunas, Lithuania)|November 11, 2022
Management of Nelson's SyndromeAthanasios Fountas, Niki Karavitaki
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 15, 2019
Re: Clover et al. Transformation of a non-secretory neuro-endocrine tumor to insulinoma after treatment with Sunitinib: a case report and review of the literature. J Oncol Pharm Pract 2018. DOI: 10.1177/1078155218791309: Sunitinib-associated hyperinsulinemic hypoglycemia in patients with neuroendocrine tumors: drug-effect or tumor transformation?Athanasios Fountas, Stelios Tigas
BMJ (Clinical Research Ed.)|February 26, 2015
A 45 year old patient with headache, fever, and hyponatraemiaAthanasios Fountas, Maria Andrikoula, Agathocles Tsatsoulis
The Lancet. Diabetes & Endocrinology|October 19, 2019
Opioid-induced endocrinopathiesAthanasios Fountas, Stan Van Uum, Niki Karavitaki
Trends in Endocrinology and Metabolism: TEM|October 24, 2015
Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?Athanasios Fountas, Leonidas-Nikolaos Diamantopoulos, Agathocles Tsatsoulis
Cleveland Clinic Journal of Medicine|January 2, 2015
Insulin therapy and cancer risk (October 2014)Athanasios Fountas, Georgia Rosiou, Agathocles A Tsatsoulis
Trends in Endocrinology and Metabolism: TEM|March 3, 2018
Erratum to 'Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?': [Trends in Endocrinology & Metabolism 26 (2015) 643-656]Athanasios Fountas, Leonidas-Nikolaos Diamantopoulos, Agathocles Tsatsoulis
Pituitary|January 19, 2018
Mortality in patients with non-functioning pituitary adenomaMetaxia Tampourlou, Athanasios Fountas, Georgia Ntali, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Endocrinology and Metabolism Clinics of North America|August 4, 2020
Nelson's Syndrome: An UpdateAthanasios Fountas, Niki Karavitaki
European Journal of Endocrinology|October 18, 2024
Response to commentary "Vasopressin deficiency following operated craniopharyngiomas: fear or fatality?"Athanasios Fountas, Niki Karavitaki
Medicina (Kaunas, Lithuania)|November 11, 2022
Management of Nelson's SyndromeAthanasios Fountas, Niki Karavitaki
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 15, 2019
Re: Clover et al. Transformation of a non-secretory neuro-endocrine tumor to insulinoma after treatment with Sunitinib: a case report and review of the literature. J Oncol Pharm Pract 2018. DOI: 10.1177/1078155218791309: Sunitinib-associated hyperinsulinemic hypoglycemia in patients with neuroendocrine tumors: drug-effect or tumor transformation?Athanasios Fountas, Stelios Tigas
BMJ (Clinical Research Ed.)|February 26, 2015
A 45 year old patient with headache, fever, and hyponatraemiaAthanasios Fountas, Maria Andrikoula, Agathocles Tsatsoulis
The Lancet. Diabetes & Endocrinology|October 19, 2019
Opioid-induced endocrinopathiesAthanasios Fountas, Stan Van Uum, Niki Karavitaki
Trends in Endocrinology and Metabolism: TEM|October 24, 2015
Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?Athanasios Fountas, Leonidas-Nikolaos Diamantopoulos, Agathocles Tsatsoulis
Cleveland Clinic Journal of Medicine|January 2, 2015
Insulin therapy and cancer risk (October 2014)Athanasios Fountas, Georgia Rosiou, Agathocles A Tsatsoulis
Trends in Endocrinology and Metabolism: TEM|March 3, 2018
Erratum to 'Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?': [Trends in Endocrinology & Metabolism 26 (2015) 643-656]Athanasios Fountas, Leonidas-Nikolaos Diamantopoulos, Agathocles Tsatsoulis
Pituitary|January 19, 2018
Mortality in patients with non-functioning pituitary adenomaMetaxia Tampourlou, Athanasios Fountas, Georgia Ntali, et al.
Pageof 4